Pneumatic Compression Therapy Market Report 2026

The pneumatic compression therapy market size has grown strongly in recent years. It will grow from $3.6 billion in 2025 to $3.86 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing prevalence of venous disorders, growing awareness of compression therapy benefits, expansion of post-surgical rehabilitation care, increased use of non-invasive treatment options, availability of portable compression devices.

The pneumatic compression therapy market size is expected to see strong growth in the next few years. It will grow to $5.05 billion in 2030 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to increasing demand for remote patient monitoring, rising adoption of smart medical devices, expansion of home healthcare services, growing focus on chronic disease management, technological advancements in pneumatic therapy systems. Major trends in the forecast period include increasing adoption of home-based compression therapy devices, rising demand for programmable compression systems, growing integration of smart monitoring features, expansion of lymphedema management solutions, enhanced focus on patient comfort and compliance.

The growing number of orthopedic patients is expected to drive the growth of the pneumatic compression therapy market going forward. Orthopedics is a medical specialty focused on the diagnosis, treatment, and prevention of disorders affecting the bones, joints, muscles, ligaments, tendons, nerves, and skin. Pneumatic compression therapy supports orthopedic patients by helping to prevent the formation of blood clots in deep veins. For instance, in 2024, according to GOV.UK, a UK based government agency, during the 2023 to 2024 period compared with the 2022 to 2023 financial year, the number of operations submitted for mandatory orthopedic surveillance increased by 7.3%, rising from 102,027 operations, while voluntary surveillance increased by 13.3%, up from 23,070 operations. Overall, this represented an 8.4% increase across all categories. Therefore, the increasing number of orthopedic patients is contributing to the growth of the pneumatic compression therapy market.

Major companies operating in the pneumatic compression therapy market are focusing on innovative advancements, such as the development of compression sleeves, to expand their customer base and drive revenue growth. Compression sleeves are specialized garments designed to apply targeted pressure to specific areas of the body, most commonly the arms or legs. For instance, in June 2023, Recovery Systems, a Singapore based recovery solutions provider, introduced the Atom calf air compression sleeve. This device is designed to support rapid recovery and improve leg comfort, offering versatility and convenience for use in various settings, including during travel to help reduce leg swelling. Its compact and portable design, combined with effective performance, helps enhance blood circulation and reduce inflammation in the lower limbs.

In January 2024, DHG Holding AG, a Switzerland based medical device manufacturer, acquired MediCauce SL for an undisclosed amount. Through this acquisition, DHG Holding AG aims to strengthen its market presence in Spain and expand its ability to deliver comprehensive pneumatic compression therapy solutions, ultimately improving care for patients with mobility related needs. MediCauce SL is a Spain based company that provides solutions focused on safe movement and handling, pressure ulcer prevention, hygiene, and rehabilitation.

Major companies operating in the pneumatic compression therapy market are Medtronic plc, Tactile Systems Technology Inc., ArjoHuntleigh Getinge AB, Mego Afek Ltd., Medline Industries Inc., DJO Global Inc., Bio Compression Systems Inc., Talley Group Limited, Xiamen Senyang Co. Ltd., Devon Medical Inc., Bösl Medizintechnik, Thuasne SAS, ACI Medical LLC, Sanyleg Srl, Cardinal Health Inc., Gottfried Medical Inc., BSN Medical GmbH, Sigvaris Group, Medi GmbH & Co., Hartmann AG, BTL Industries Inc., Dolsan Medical Equipment Industry, FlowAid Medical Technologies Corp., Huntleigh Healthcare Limited, Julius Zorn GmbH.

North America was the largest region in the pneumatic compression therapy market in 2025. The regions covered in the pneumatic compression therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pneumatic compression therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the pneumatic compression therapy market by increasing costs of imported pneumatic pumps, electronic control units, pressure sensors, and medical-grade textiles used in sleeves and garments. Healthcare providers in North America and Europe are most affected due to reliance on imported devices, while Asia-Pacific faces higher component costs for manufacturing and exports. These tariffs are increasing device prices and slowing adoption in cost-sensitive settings. However, they are also encouraging local device assembly, regional sourcing of components, and development of cost-efficient pneumatic compression systems.

The pneumatic compression therapy market research report is one of a series of new reports that provides pneumatic compression therapy market statistics, including pneumatic compression therapy industry global market size, regional shares, competitors with a pneumatic compression therapy market share, detailed pneumatic compression therapy market segments, market trends and opportunities, and any further data you may need to thrive in the pneumatic compression therapy industry. This pneumatic compression therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pneumatic compression therapy is a treatment approach that uses devices consisting of inflatable arm or leg garments connected to an electric pneumatic pump that fills the garments with compressed air. This therapy applies controlled pressure to enhance blood circulation in the limbs and support blood flow back to the heart.

The primary products used in pneumatic compression therapy include pneumatic compression sleeves, segmented pneumatic compression pumps, programmable pneumatic compression pumps, non programmable pneumatic compression pumps, and non segmented pneumatic compression pumps. Inflatable sleeves are typically worn on the lower limbs during hospital recovery following illness or surgery. The therapy techniques include static compression therapy and dynamic compression therapy and are applied across various indications such as varicose vein treatment, deep vein thrombosis treatment, lymphedema treatment, and other conditions. These therapies are utilized in hospitals and clinics, nursing care centers, home care environments, and other settings.

The pneumatic compression therapy market includes revenues earned by entities by providing pain experimental/investigational (E/I) services, pain management. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.